Dr. Benjamin B. Brannick, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Mercer University School of Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 689
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2012Medical school: Mercer University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TN license 56134 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Hospitals of Memphis Memphis, TN
- Baptist Memorial Hospital Memphis, TN
- Baptist Memorial Hospital Desoto Southaven, MS
- Baptist Memorial Hospital Tipton Covington, TN
- Baptist Memorial Hospital Union County New Albany, MS
Medical groups
- Baptist Memorial Medical Group, Inc. (576 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 689
- Services billed
- 5,038
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 866 | 549 |
| Blood glucose (sugar) test performed by hand-held instrument | 610 | 367 |
| Hemoglobin a1c level | 519 | 341 |
| Insertion of needle into vein for collection of blood sample | 317 | 249 |
| Blood test, thyroid stimulating hormone (tsh) | 193 | 149 |
| Thyroxine (thyroid chemical), free | 191 | 146 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 142 | 86 |
| Blood test, comprehensive group of blood chemicals | 134 | 120 |
| Thyroid hormone, t3 measurement, free | 120 | 94 |
| New patient office or other outpatient visit, 45-59 minutes | 117 | 117 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ozempic (semaglutide) Other prescribers in Memphis, TN | 685 |
| Mounjaro (tirzepatide) Other prescribers in Memphis, TN | 493 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Memphis, TN | 340 |
| Jardiance (empagliflozin) Other prescribers in Memphis, TN | 340 |
| Levothyroxine Sodium Other prescribers in Memphis, TN | 332 |
| Glipizide Other prescribers in Memphis, TN | 250 |
| Novolog Flexpen (insulin aspart) Other prescribers in Memphis, TN | 217 |
| Metformin Hcl Other prescribers in Memphis, TN | 205 |
| Soliqua 100-33 (insulin glargine/lixisenatide) Other prescribers in Memphis, TN | 201 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Memphis, TN | 197 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 32 companies reported 178 payments worth $21,362 in total to this clinician.
| Xeris Pharmaceuticals, Inc. | $18,153 |
|---|---|
| Amgen Inc. | $374 |
| Sequel Med Tech, LLC | $354 |
| Lilly USA, LLC | $257 |
| AbbVie Inc. | $225 |
| Novo Nordisk Inc | $224 |
| Corcept Therapeutics | $200 |
| Kyowa Kirin, Inc. | $192 |
| Honoraria | $14,175 |
|---|---|
| Food and Beverage | $3,820 |
| Travel and Lodging | $3,367 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. Mar 4, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $3,465 |
| Xeris Pharmaceuticals, Inc. Apr 1, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $2,205 |
| Xeris Pharmaceuticals, Inc. Jan 14, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,890 |
| Xeris Pharmaceuticals, Inc. Apr 17, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,890 |
| Xeris Pharmaceuticals, Inc. Feb 4, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Waikoloa, HI · in-kind | $1,677 |
| Xeris Pharmaceuticals, Inc. Apr 2, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,575 |
| Xeris Pharmaceuticals, Inc. Jun 2, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,260 |
| Xeris Pharmaceuticals, Inc. Aug 18, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,260 |
| Xeris Pharmaceuticals, Inc. Feb 4, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Waikoloa, HI · in-kind | $1,040 |
| Xeris Pharmaceuticals, Inc. Mar 3, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $630 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. Aug 18, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,260 |
| Xeris Pharmaceuticals, Inc. Jun 2, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,260 |
| Xeris Pharmaceuticals, Inc. Apr 17, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,890 |
| Xeris Pharmaceuticals, Inc. Apr 17, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Coldwater, MS | $54.60 |
| Xeris Pharmaceuticals, Inc. Apr 2, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,575 |
| Xeris Pharmaceuticals, Inc. Apr 1, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $2,205 |
| Xeris Pharmaceuticals, Inc. Apr 1, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Knoxville, TN | $515 |
| Xeris Pharmaceuticals, Inc. Mar 4, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $3,465 |
| Xeris Pharmaceuticals, Inc. Mar 3, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $630 |
| Xeris Pharmaceuticals, Inc. Feb 4, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Waikoloa, HI · in-kind | $1,677 |
| Xeris Pharmaceuticals, Inc. Feb 4, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Waikoloa, HI · in-kind | $1,040 |
| Xeris Pharmaceuticals, Inc. Feb 4, 2025 | Travel and Lodging RECORLEV · Adrenal steroidogenesis inhibitor · travel to Waikoloa, HI · in-kind | $80.00 |
| Xeris Pharmaceuticals, Inc. Jan 14, 2025 | Honoraria RECORLEV · Adrenal steroidogenesis inhibitor | $1,890 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.